BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19860845)

  • 21. CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.
    Wang X; Zhang Y; Zhao Y; Liang Y; Xiang C; Zhou H; Zhang H; Zhang Q; Qing H; Jiang B; Xiong H; Peng L
    Oncotarget; 2016 Aug; 7(34):55663-55676. PubMed ID: 27494878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
    Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in human colon cancer cells.
    Zhan Y; Gong K; Chen C; Wang H; Li W
    Free Radic Biol Med; 2012 Aug; 53(3):532-43. PubMed ID: 22634147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells.
    Shin I; Kim S; Song H; Kim HR; Moon A
    J Biol Chem; 2005 Apr; 280(15):14675-83. PubMed ID: 15677464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in BRAF-Mutated Colorectal Cancers.
    Tang Z; Yuan X; Du R; Cheung SH; Zhang G; Wei J; Zhao Y; Feng Y; Peng H; Zhang Y; Du Y; Hu X; Gong W; Liu Y; Gao Y; Liu Y; Hao R; Li S; Wang S; Ji J; Zhang L; Li S; Sutton D; Wei M; Zhou C; Wang L; Luo L
    Mol Cancer Ther; 2015 Oct; 14(10):2187-97. PubMed ID: 26208524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
    Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
    J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAPK/ERK pathway inhibition is a promising treatment target for adrenocortical tumors.
    Pereira SS; Monteiro MP; Costa MM; Ferreira J; Alves MG; Oliveira PF; Jarak I; Pignatelli D
    J Cell Biochem; 2019 Jan; 120(1):894-906. PubMed ID: 30256438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raf-1 is activated by the p38 mitogen-activated protein kinase inhibitor, SB203580.
    Kalmes A; Deou J; Clowes AW; Daum G
    FEBS Lett; 1999 Feb; 444(1):71-4. PubMed ID: 10037150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
    Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
    Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology.
    Ng DC; Long CS; Bogoyevitch MA
    J Biol Chem; 2001 Aug; 276(31):29490-8. PubMed ID: 11382751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells.
    Le XF; Arachchige-Don AS; Mao W; Horne MC; Bast RC
    Mol Cancer Ther; 2007 Nov; 6(11):2843-57. PubMed ID: 18025271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low concentrations of nitric oxide (NO) induced cell death in PC12 cells through activation of p38 mitogen-activated protein kinase (p38 MAPK) but not via extracellular signal-regulated kinases (ERK1/2) or c-Jun N-terminal protein kinase (JNK).
    Yamamoto T; Yuyama K; Yamamoto H
    Neurosci Lett; 2006 Jan; 392(3):170-3. PubMed ID: 16198052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluid shear stress stimulates osteogenic differentiation of human periodontal ligament cells via the extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling pathways.
    Tang M; Peng Z; Mai Z; Chen L; Mao Q; Chen Z; Chen Q; Liu L; Wang Y; Ai H
    J Periodontol; 2014 Dec; 85(12):1806-13. PubMed ID: 25186781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF.
    McLeish KR; Knall C; Ward RA; Gerwins P; Coxon PY; Klein JB; Johnson GL
    J Leukoc Biol; 1998 Oct; 64(4):537-45. PubMed ID: 9766635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells.
    Chowchaikong N; Nilwarangkoon S; Laphookhieo S; Tanunyutthawongse C; Watanapokasin R
    Int J Oncol; 2018 Jun; 52(6):2031-2040. PubMed ID: 29620273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.
    Wilhelm SM; Carter C; Tang L; Wilkie D; McNabola A; Rong H; Chen C; Zhang X; Vincent P; McHugh M; Cao Y; Shujath J; Gawlak S; Eveleigh D; Rowley B; Liu L; Adnane L; Lynch M; Auclair D; Taylor I; Gedrich R; Voznesensky A; Riedl B; Post LE; Bollag G; Trail PA
    Cancer Res; 2004 Oct; 64(19):7099-109. PubMed ID: 15466206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
    Swart JM; Bergeron DM; Chiles TC
    J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of mitogen-activated protein kinases in the modulation of endothelial cell function following thermal injury.
    Wu W; Huang Q; He F; Xiao M; Pang S; Guo X; Brunk UT; Zhao K; Zhao M
    Shock; 2011 Jun; 35(6):618-25. PubMed ID: 21263381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.